KEY vs SYRE · P/E 13, rev $3.92B vs $7.60B cap
KeyCorp (KEY) versus Spyre Therapeutics Inc. (SYRE) — a side-by-side from cached financials, not a winner call.
KeyCorp (KEY) is a banks - regional company listed on US.
Spyre Therapeutics Inc. (SYRE) is a biotechnology company listed on NASDAQ.
Latest reported KEY revenue for 2026-06-30 was $3.92B. Net income was $1.03B. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Latest reported SYRE revenue for 2025-12-31 was $0. Net income was -$155.2M. SYRE currently screens at market cap $7.60B.
KEY currently screens at market cap $22.64B and trailing P/E 12.8. SYRE currently screens at market cap $7.60B.
Not investment advice. Open the KEY and SYRE stock pages for the full models.
Not investment advice.